z-logo
Premium
The x   c − cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: Yet another cytotoxic anticancer approach?
Author(s) -
Savaskan Nic E.,
Hahnen Eric,
Eyüpoglu Ilker Y.
Publication year - 2009
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.21795
Subject(s) - notice , cytotoxic t cell , cystine , cancer therapy , cancer cell , antiporter , chemistry , glutamate receptor , cancer research , cancer , biology , biochemistry , genetics , in vitro , membrane , political science , law , enzyme , cysteine , receptor
This article was published online on 4 May 2009. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected 8 June 2009.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom